NCT06498375

Brief Summary

Evaluation of fluid status in cardiac surgery patients using bioelectrical impedance and its impact on postoperative morbidity and mortality

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2024Jul 2026

First Submitted

Initial submission to the registry

June 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

June 26, 2024

Last Update Submit

July 4, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Phase angle (in degrees)

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Impedance ratio

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Total body water (TBW), extracellular water (ECW), intracellular water (ICW) (in litres)

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Oedema index (ECW/TBW ratio)

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Body cell mass (in kilograms)

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Skeletal muscle mass (in kilograms)

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

  • Fluid distribution during the early postoperative period (≤ 5 days)

    Bioelectrical impedance vector analysis

    Perioperative period (preoperatively, on the first, third, and fifth postoperative day)

Secondary Outcomes (6)

  • Impact of fluid distribution/fluid overload on duration of postoperative mechanical ventilation

    Duration of stay in ICU (estimated to up to 5 days)

  • Impact of fluid distribution/fluid overload on postoperative complications (myocardial infarction, cardiogenic shock, vasoplegia, atrial fibrillation, heart failure, bleeding, infections, delirium)

    Up to 1 year after the operation

  • Impact of fluid distribution/fluid overload on length of stay in the intensive care unit

    Duration of stay in ICU (estimated to up to 5 days)

  • Impact of fluid distribution/fluid overload on length of hospitalisation

    Duration of hospital stay (up to 1 month)

  • Impact of fluid distribution/fluid overload on 30-day postoperative mortality

    On day 30

  • +1 more secondary outcomes

Study Arms (2)

On-pump cardiac surgery

Patients undergoing cardiac surgery with cardiopulmonary bypass

Diagnostic Test: Bioelectrical impedance

Off-pump cardiac surgery

Patients undergoing cardiac surgery without cardiopulmonary bypass

Diagnostic Test: Bioelectrical impedance

Interventions

Fluid distribution measured by bioelectrical impedance Bodystat Multiscan 5000 Bodystat Ltd, Isle of Man, British Isles

Off-pump cardiac surgeryOn-pump cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults (18 years or over) undergoing elective cardovascular surgery (on-pump or off-pump)

You may qualify if:

  • Elective cardiovascular surgery (on-pump or off-pump)
  • Age ≥ 18 years
  • ASA 3 or 4
  • Provided verbal and written informed consent

You may not qualify if:

  • Refusal to participate in the research
  • \< 18 years
  • Renal failure requiring replacement treatment with hemodialysis
  • Amputation of a limb
  • Pregnancy
  • Emergency Procedures
  • Reoperation
  • Pacemaker/implantable cardioverter-defibrillator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana

Ljubljana, Slovenia

Location

MeSH Terms

Conditions

Pulmonary Heart DiseaseEdema

Interventions

Electric Impedance

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric ConductivityElectricityElectromagnetic PhenomenaMagnetic PhenomenaPhysical Phenomena

Study Officials

  • Gordana Taleska Štupica, MD, PhD, DESA, EDIC

    Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana

    STUDY CHAIR
  • Laura Kekec, MD

    Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana

    PRINCIPAL INVESTIGATOR
  • Matej Jenko, MD

    Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana

    STUDY DIRECTOR
  • Maja Šoštarič, MD, PhD

    Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 26, 2024

First Posted

July 12, 2024

Study Start

July 1, 2024

Primary Completion

July 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

July 12, 2024

Record last verified: 2024-07

Locations